Rezultati - Christiane Chen‐Santel
- Showing 1 - 6 results of 6
-
1
Blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia: results of the RIALTO trial, an expanded access study od Franco Locatelli, Gerhard Zugmaier, Noemi Mergen, Peter Bader, Sima Jeha, Paul-Gerhardt Schlegel, Jean‐Pierre Bourquin, Rupert Handgretinger, Benoît Brethon, Claudia Rössig, Christiane Chen‐Santel
Izdano 2020Carta -
2
Blinatumomab in pediatric relapsed/refractory B-cell acute lymphoblastic leukemia: RIALTO expanded access study final analysis od Franco Locatelli, Gerhard Zugmaier, Noemi Mergen, Peter Bader, Sima Jeha, Paul‐Gerhardt Schlegel, Jean‐Pierre Bourquin, Rupert Handgretinger, Benoît Brethon, Claudia Rössig, William Kormany, Puneeth Viswagnachar, Christiane Chen‐Santel
Izdano 2022Artigo -
3
Risk factors and outcomes in children with high-risk B-cell precursor and T-cell relapsed acute lymphoblastic leukaemia: combined analysis of ALLR3 and ALL-REZ BFM 2002 clinical tr... od Cornelia Eckert, Catriona Parker, Anthony V. Moorman, Julie Irving, Renate Kirschner‐Schwabe, Stefanie Groeneveld‐Krentz, Tamás Révész, Peter M. Hoogerbrugge, Jeremy Hancock, Rosemary Sutton, Guenter Henze, Christiane Chen‐Santel, Andishe Attarbaschi, Jean‐Pierre Bourquin, Lucie Šrámková, Martin Zimmermann, Shekhar Krishnan, Arend von Stackelberg, Vaskar Saha
Izdano 2021Artigo -
4
Durable remissions in <i>TCF3-HLF</i> positive acute lymphoblastic leukemia with blinatumomab and stem cell transplantation od Brice Mouttet, Luciana Vinti, Philip Ancliff, Nicole Bodmer, Benoît Brethon, Gunnar Cario, Christiane Chen‐Santel, Sarah Elitzur, Volkan Hazar, Joachim B. Kunz, Anja Möricke, Jerry Stein, Ajay Vora, Yöntem Yaman, Martin Schrappe, Sema Anak, André Baruche, Franco Locatelli, Arend von Stackelberg, Martin Stanulla, Jean‐Pierre Bourquin
Izdano 2019Carta -
5
A phase 1 study of inotuzumab ozogamicin in pediatric relapsed/refractory acute lymphoblastic leukemia (ITCC-059 study) od Erica Brivio, Franco Locatelli, Marta López‐Yurda, Andrea Malone, Cristina Díaz de Heredia, Bella Bielorai, Claudia Rössig, Vincent H. J. van der Velden, Anneke C. J. Ammerlaan, Adriana Thano, Inge M. van der Sluis, Monique L. den Boer, Ying Chen, Barbara Sleight, Benoît Brethon, Karsten Nysom, Lucie Šrámková, Ingrid Øra, Luciana Vinti, Christiane Chen‐Santel, C. Michel Zwaan
Izdano 2020Artigo -
6
Inotuzumab ozogamicin as single agent in pediatric patients with relapsed and refractory acute lymphoblastic leukemia: results from a phase II trial od Edoardo Pennesi, Naomi Michels, Erica Brivio, Vincent H. J. van der Velden, Yilin Jiang, Adriana Thano, Anneke J. C. Ammerlaan, Judith M. Boer, H. Berna Beverloo, Barbara Sleight, Ying Chen, Britta Vormoor-Bürger, Susana Rives, Bella Bielorai, Claudia Rössig, Arnaud Petit, Carmelo Rizzari, Gernot Engstler, Jan Starý, Francisco Bautista, Christiane Chen‐Santel, Bénédicte Bruno, Yves Bertrand, Fanny Rialland, Geneviève Plat, Dirk Reinhardt, Luciana Vinti, Arend von Stackelberg, Franco Locatelli, C. Michel Zwaan
Izdano 2022Artigo
Iskalna orodja:
Sorodne teme
Internal medicine
Medicine
Leukemia
Astrobiology
Lymphoblastic Leukemia
Oncology
Refractory (planetary science)
Blinatumomab
Pediatrics
Physics
Biology
Clinical trial
Acute lymphocytic leukemia
CD20
CD22
Calicheamicin
Cancer
Cancer research
Environmental health
Gastroenterology
Genetics
Hematopoietic stem cell transplantation
Immunology
Lymphoma
Minimal residual disease
Myeloid leukemia
Pediatric oncology
Phases of clinical research
Population
Stem cell